Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul 29;5(3):229-236.
doi: 10.23922/jarc.2020-102. eCollection 2021.

Evaluation of the Amounts of Sennosides A and B in Rhubarb-containing Kampo Medicines to Create a Ranking of Kampo Medicines for Appropriate Selection of Laxatives

Affiliations

Evaluation of the Amounts of Sennosides A and B in Rhubarb-containing Kampo Medicines to Create a Ranking of Kampo Medicines for Appropriate Selection of Laxatives

Kakuyou Ogawa et al. J Anus Rectum Colon. .

Abstract

Objectives: To evaluate 20 Kampo medicines, which comprised 6 formulas, Otsujito, Junchoto, Tokakujokito, Bofutsushosan, Mashiningan, and Keishikashakuyakudaioto, from 7 brands, to create a ranking of Kampo medicines for appropriate selection of laxatives.

Methods: The amounts of sennosides A and B, the important components showing laxative effects contained in Kampo medicines, were analysed using High Performance Liquid Chromatography.

Results: We found that the amounts of sennosides A and B were different among brands, even when they had the same formula. Furthermore, the amounts of sennosides differed when the same amounts of rhubarb were used.

Conclusions: These results suggest that the differences in amounts of sennosides are caused by the quality of the rhubarb used. Kampo medicines containing laxatives other than rhubarb, including disodium sulphate and hemp seed, had synergistic laxative effects. Thus, in the future, it may be possible to adjust laxative potency of Kampo medicines through further clinical tests.

Keywords: Kampo Medicines; Rhubarb; Sennosides A and B; Strength of laxative effects.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest There are no conflicts of interest.

Figures

Figure 1.
Figure 1.
Main metabolic pathway of sennosides by human gastrointestinal microbiota.
Figure 2.
Figure 2.
Standard curves for sennosides A and B.

References

    1. Shoyama Y, Morinaga O, Cai SQ. Rheum palmatum. Med Drug J. 2009 Aug;45:5-15.
    1. Ministry of Health, Labour and Welfare. The Japanese pharmacopoeia seventeenth edition (JPXVII). Tokyo: Jiho; 2016. 1844 p.
    1. Takeya K, Kiuchi F, Komatsu K. Partner pharmacognosy. 3rd ed. Tokyo: Nankodo; 2017. p. 146-8.
    1. Hattori M, Namba T, Akao T, Kobayashi K. Metabolism of sennosides by human intestinal bacteria. Pharmacol. 1988 Jul;36(suppl 1):172-9. - PubMed
    1. Matsuoka Y, Kubota K. Laxatives and peristaltic stimulants. Nippon Rinsho. 1991 Jun;49(special issue 2):384-7.